Cargando…
A Designer Nanoparticle Platform for Controlled Intracellular Delivery of Bioactive Macromolecules: Inhibition of Ubiquitin-Specific Protease 7 in Breast Cancer Cells
[Image: see text] Biological therapeutics represent an increasing and critical component of newly approved drugs; however, the inability to deliver biologics intracellularly in a controlled manner remains a major limitation. We have developed a semi-synthetic, tunable phage-like particle (PLP) platf...
Autores principales: | McClary, Wynton D., Catala, Alexis, Zhang, Wei, Gamboni, Fabia, Dzieciatkowska, Monika, Sidhu, Sachdev S., D’Alessandro, Angelo, Catalano, Carlos E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295703/ https://www.ncbi.nlm.nih.gov/pubmed/35796308 http://dx.doi.org/10.1021/acschembio.2c00256 |
Ejemplares similares
-
Red Blood Cells from Individuals with Lesch–Nyhan Syndrome: Multi-Omics Insights into a Novel S162N Mutation Causing Hypoxanthine-Guanine Phosphoribosyltransferase Deficiency
por: Reisz, Julie A., et al.
Publicado: (2023) -
ARMMs as a versatile platform for intracellular delivery of macromolecules
por: Wang, Qiyu, et al.
Publicado: (2018) -
Development of inhibitors in the ubiquitination cascade
por: Zhang, Wei, et al.
Publicado: (2014) -
Bioactivation and covalent binding of halothane to liver macromolecules.
por: Sipes, I G, et al.
Publicado: (1977) -
Polysaccharides: potential bioactive macromolecules for Alzheimer’s disease
por: Peng, Gong, et al.
Publicado: (2023)